Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis
- 1 July 1992
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 103 (1) , 65-71
- https://doi.org/10.1016/0016-5085(92)91096-m
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Interleukin 1: the first interleukinImmunology Today, 1990
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.Journal of Clinical Investigation, 1990
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.Journal of Clinical Investigation, 1990
- Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins.Journal of Clinical Investigation, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.The Journal of Experimental Medicine, 1989
- Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.Gut, 1989